Short Non-coding RNA Biomarkers of Predisposition to Ovarian Cancer

Status unconfirmed

Conditions studied: Ovarian Cancer

In brief

The purpose of this study is to create new tests to identify biomarkers for ovarian cancer so that a screening test can be developed. For patients who have a diagnosis of ovarian Cancer, researchers will use blood samples before and after treatment to see if disease status can be determined by measuring the amount of biomarker.

Key facts

Study ID

NCT01187602

Run by

University of Virginia

People needed

103

Starts

2010-08-01

Expected to finish

2015-06-01

Last updated by the study team

2014-12-05

Who can join

Age: 18 and older, up to 90. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Undergoing medical care at UVA
• Up to date breast cancer screening
• Subjects must fall into one of the following groups:
• Women at increased risk of ovarian cancer based on family history, personal history, or genetic factors defined as either BRCA1 or BRCA2 mutations who still retain both fallopian tubes and both ovaries.
• Women at average risk for ovarian cancer
• Women with known/suspected or recurrent ovarian cancer who are undergoing evaluation and/or treatment at UVA Cancer Center

You may not qualify if…

• Subjects with increased risk for ovarian cancer may not have a history of prior malignancy within the last 10 years excluding cervical carcinoma in situ or basal cell carcinoma
• Pregnancy (self reported)

Where it is running

• University of Virginia — Charlottesville, Virginia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.